Skip to main content
. Author manuscript; available in PMC: 2014 Dec 30.
Published in final edited form as: Stroke. 2014 Jan 2;45(2):456–461. doi: 10.1161/STROKEAHA.113.004001

Table 2.

Included Patients With Mutually Interpretable Perfusion Scans

Age, y Sex Hours From Onset
to Initial/Follow-Up
Scan
Treatment Stroke Vascular
Territory
Consensus ASL
Reads
Consensus DSC
Reads
Perfusion Volume
Change, %
70 M 2.9/23.6 IV tPA (OH) Left MCA No reperfusion No reperfusion 25
44 M 5.7/28.2 IV tPA (OH) Left MCA, left lenticulostriate No reperfusion No reperfusion −9
36 M 1.5/27.5 IV tPA (AH) Right MCA No reperfusion No reperfusion −10
36 F 3.5/30.0 IA tPA, Reapro* (AH) Left MCA No reperfusion No reperfusion −2
66 M 6.2/36.0 IV tPA (OH) Left MCA No reperfusion No reperfusion −26
75 F 1.1/28.1 IV tPA (AH) Left MCA Reperfusion No reperfusion −19
88 F 3.6/24.6 IV tPA (OH) Right MCA Reperfusion Reperfusion −100
75 F 1.6/25.4 IV tPA, IA tPA (AH) Left MCA Reperfusion Reperfusion −92
48 F 3.4/33.6 IV tPA (AH) Right PCA Reperfusion Reperfusion −100
49 F 1.1/25.7 IV tPA (AH) Right MCA Reperfusion Reperfusion −100
78 F 6.9/30.1 None* (AH) Left MCA Reperfusion Reperfusion −43
70 M 1.7/37.4 IV tPA (AH) Left PCA Reperfusion Reperfusion −35
35 F 5.6/34.1 IV tPA (OH) Right MCA Reperfusion Reperfusion −90

AH indicates admission hospital; F, female; IA, intra-arterial; IV, intravenous; M, male; MCA, middle cerebral artery; OH, outside hospital; PCA, posterior cerebral artery; and tPA, tissue-type plasminogen activator.

*

Patient presented beyond therapeutic time window for IV tPA or IA tPA.